In addition to formulating diagnostic strategies for cancer immunotherapy agents, her team is focused on developing a deep understanding of tumor immune biology as well as mechanisms associated with immune response and immune escape in cancer patients, with the intent of
generating rational strategies for the creation of combination therapies.
Not exact matches
Rational Bear delivers well - researched hedging
strategies for your long portfolio, to help you
generate profit in the event of a swift market correction... Read more»
«The NuWave team developed a successful
strategy to
generate both alpha and beta for investors seeking U.S. equity exposure, and
Rational Funds is proud to bring this
strategy to all investors» — Jerry Szilagyi, CEO of
Rational Funds
«The NuWave team developed a successful
strategy to
generate both alpha and beta for investors seeking U.S. equity exposure, and
Rational Funds is proud to bring this
strategy to all investors,» said Jerry Szilagyi, CEO of
Rational Funds.